Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Oncology Drugs Market, by Indication
1.4.2 Europe Oncology Drugs Market, by Drug Class Type
1.4.3 Europe Oncology Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2019, Mar – 2023, Nov) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. Europe Oncology Drugs Market by Indication
5.1 Europe Breast Cancer Market by Country
5.2 Europe Prostate Cancer Market by Country
5.3 Europe Lung Cancer Market by Country
5.4 Europe Stomach Cancer Market by Country
5.5 Europe Colorectal Cancer Market by Country
5.6 Europe Liver Cancer Market by Country
5.7 Europe Esophagus Cancer Market by Country
5.8 Europe Cervical Cancer Market by Country
5.9 Europe Kidney Cancer Market by Country
5.10. Europe Bladder Cancer Market by Country
5.11 Europe Other Cancer Market by Country
Chapter 6. Europe Oncology Drugs Market by Drug Class Type
6.1 Europe Targeted Therapy Market by Country
6.2 Europe Immunotherapy (Biologic Therapy) Market by Country
6.3 Europe Chemotherapy Market by Country
6.4 Europe Hormonal Therapy Market by Country
Chapter 7. Europe Oncology Drugs Market by Country
7.1 Germany Oncology Drugs Market
7.1.1 Germany Oncology Drugs Market by Indication
7.1.2 Germany Oncology Drugs Market by Drug Class Type
7.2 UK Oncology Drugs Market
7.2.1 UK Oncology Drugs Market by Indication
7.2.2 UK Oncology Drugs Market by Drug Class Type
7.3 France Oncology Drugs Market
7.3.1 France Oncology Drugs Market by Indication
7.3.2 France Oncology Drugs Market by Drug Class Type
7.4 Russia Oncology Drugs Market
7.4.1 Russia Oncology Drugs Market by Indication
7.4.2 Russia Oncology Drugs Market by Drug Class Type
7.5 Spain Oncology Drugs Market
7.5.1 Spain Oncology Drugs Market by Indication
7.5.2 Spain Oncology Drugs Market by Drug Class Type
7.6 Italy Oncology Drugs Market
7.6.1 Italy Oncology Drugs Market by Indication
7.6.2 Italy Oncology Drugs Market by Drug Class Type
7.7 Rest of Europe Oncology Drugs Market
7.7.1 Rest of Europe Oncology Drugs Market by Indication
7.7.2 Rest of Europe Oncology Drugs Market by Drug Class Type
Chapter 8. Company Profiles
8.1 AbbVie, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Amgen, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Astellas Pharma, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 AstraZeneca PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.6 SWOT Analysis
8.5 Bristol Myers Squibb Company
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Acquisition and Mergers:
8.5.6 SWOT Analysis
8.6 F. Hoffmann-La Roche Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Johnson & Johnson
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental & Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.7.6 SWOT Analysis
8.8 Novartis AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.6 SWOT Analysis
8.9 Merck & Co., Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.5.2 Acquisition and Mergers:
8.9.6 SWOT Analysis
8.10. Pfizer, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional & Segmental Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.6 SWOT Analysis



List of Figures

FIG 1 Methodology for the research
FIG 2 Europe Oncology Drugs Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Oncology Drugs Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2019, Mar – 2023, Nov) Leading Players
FIG 7 Porter’s Five Forces Analysis - Oncology Drugs Market
FIG 8 Europe Oncology Drugs Market share by Indication, 2022
FIG 9 Europe Oncology Drugs Market share by Indication, 2030
FIG 10 Europe Oncology Drugs Market by Indication, 2019 - 2030, USD Million
FIG 11 Europe Oncology Drugs Market share by Drug Class Type, 2022
FIG 12 Europe Oncology Drugs Market share by Drug Class Type, 2030
FIG 13 Europe Oncology Drugs Market by Drug Class Type, 2019 - 2030, USD Million
FIG 14 Europe Oncology Drugs Market share by Country, 2022
FIG 15 Europe Oncology Drugs Market share by Country, 2030
FIG 16 Europe Oncology Drugs Market by Country, 2019 - 2030, USD Million
FIG 17 Recent strategies and developments: AbbVie, Inc.
FIG 18 Swot Analysis: AbbVie, Inc.
FIG 19 Swot Analysis: Amgen, Inc.
FIG 20 Recent strategies and developments: Astellas Pharma, Inc.
FIG 21 SWOT Analysis: Astellas Pharma, Inc.
FIG 22 Recent strategies and developments: AstraZeneca PLC
FIG 23 SWOT Analysis: AstraZeneca PLC
FIG 24 Recent strategies and developments: Bristol Myers Squibb Company
FIG 25 SWOT Analysis: Bristol Myers Squibb Company
FIG 26 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 27 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 28 Recent strategies and developments: Johnson & Johnson
FIG 29 Swot Analysis: Johnson & Johnson
FIG 30 SWOT Analysis: Novartis AG
FIG 31 Recent strategies and developments: Merck & Co., Inc.
FIG 32 SWOT Analysis: Merck & Co., Inc.
FIG 33 SWOT Analysis: Pfizer, Inc.

List of Tables

TABLE 1 Europe Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 2 Europe Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Oncology Drugs Market
TABLE 4 Product Launches And Product Expansions– Oncology Drugs Market
TABLE 5 Acquisition and Mergers– Oncology Drugs Market
TABLE 6 Europe Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 7 Europe Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 8 Europe Breast Cancer Market by Country, 2019 - 2022, USD Million
TABLE 9 Europe Breast Cancer Market by Country, 2023 - 2030, USD Million
TABLE 10 Europe Prostate Cancer Market by Country, 2019 - 2022, USD Million
TABLE 11 Europe Prostate Cancer Market by Country, 2023 - 2030, USD Million
TABLE 12 Europe Lung Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 13 Europe Lung Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 14 Europe Stomach Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 15 Europe Stomach Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 16 Europe Colorectal Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 17 Europe Colorectal Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 18 Europe Liver Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 19 Europe Liver Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 20 Europe Esophagus Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 21 Europe Esophagus Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 22 Europe Cervical Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 23 Europe Cervical Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 24 Europe Kidney Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 25 Europe Kidney Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 26 Europe Bladder Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 27 Europe Bladder Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 28 Europe Other Cancer Market by Country, 2019 - 2022, USD Million
TABLE 29 Europe Other Cancer Market by Country, 2023 - 2030, USD Million
TABLE 30 Europe Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 31 Europe Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 32 Europe Targeted Therapy Market by Country, 2019 - 2022, USD Million
TABLE 33 Europe Targeted Therapy Market by Country, 2023 - 2030, USD Million
TABLE 34 Europe Immunotherapy (Biologic Therapy) Market by Country, 2019 - 2022, USD Million
TABLE 35 Europe Immunotherapy (Biologic Therapy) Market by Country, 2023 - 2030, USD Million
TABLE 36 Europe Chemotherapy Market by Country, 2019 - 2022, USD Million
TABLE 37 Europe Chemotherapy Market by Country, 2023 - 2030, USD Million
TABLE 38 Europe Hormonal Therapy Market by Country, 2019 - 2022, USD Million
TABLE 39 Europe Hormonal Therapy Market by Country, 2023 - 2030, USD Million
TABLE 40 Europe Oncology Drugs Market by Country, 2019 - 2022, USD Million
TABLE 41 Europe Oncology Drugs Market by Country, 2023 - 2030, USD Million
TABLE 42 Germany Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 43 Germany Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 44 Germany Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 45 Germany Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 46 Germany Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 47 Germany Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 48 UK Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 49 UK Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 50 UK Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 51 UK Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 52 UK Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 53 UK Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 54 France Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 55 France Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 56 France Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 57 France Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 58 France Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 59 France Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 60 Russia Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 61 Russia Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 62 Russia Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 63 Russia Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 64 Russia Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 65 Russia Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 66 Spain Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 67 Spain Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 68 Spain Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 69 Spain Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 70 Spain Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 71 Spain Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 72 Italy Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 73 Italy Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 74 Italy Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 75 Italy Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 76 Italy Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 77 Italy Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 78 Rest of Europe Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 79 Rest of Europe Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 80 Rest of Europe Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 81 Rest of Europe Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 82 Rest of Europe Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 83 Rest of Europe Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 84 Key information – AbbVie, Inc.
TABLE 85 Key Information – Amgen, Inc.
TABLE 86 key information – Astellas Pharma, Inc.
TABLE 87 KEY INFORMATION – AstraZeneca PLC
TABLE 88 Key Information – Bristol Myers Squibb Company
TABLE 89 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 90 Key Information – Johnson & Johnson
TABLE 91 Key Information – Novartis AG
TABLE 92 Key Information - Merck & Co., Inc.
TABLE 93 Key Information – Pfizer, Inc.